Otsuka America

ABILIFY MAINTENA

Manufacturer:

Otsuka America

Abilify Maintena HCPCS:

J0401

HCPCS Code Descriptor:

Injection, aripiprazole, extended release, 1 mg

Category:

J Code

Abilify Maintena NDCs:

59148-0019-71, 59148-0072-80, 59148-0045-80, 59148-0018-71

Primary Type:

Psychiatric

Generic/Specialty Status:

Single-Source

Route of Administration:

Intramuscular

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Abilify Maintena:

ABILIFY MAINTENA is a Psychiatric drug manufactured by Otsuka America and administered via the Intramuscular route of administration. The J Code: J0401 is aligned to the drug ABILIFY MAINTENA.

ACCESS PRICING AND MORE BY REGISTERING

J0401 Added Date:

January 1, 2014

J0401 Effective Date:

January 1, 2014

J0401 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Abilify Maintena billing and coding information.
Abilify Maintena patient assistance information can be found through the Otsuka Patient Assistance Foundation at the URL: http://www.otsukapatientassistance.com
ABILIFY MAINTENA prescribing information can be found at the link below:
Information regarding ABILIFY MAINTENA’s side effects can be found at MedlinePlus